In a phase 3 trial, the agent reduces seizure frequency by up to 53% in treatment-resistant focal epilepsy, with rapid onset ...
Xenon Pharmaceuticals Inc.’s bull case improved after X-TOLE2 showed robust focal seizure reduction in a highly refractory ...
Ego Pharmaceuticals improved assay efficiency, reduced solvent use, and enhanced UV/Vis precision through automated ...
A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like ...
Outpatient early methadone dose titration – as recommended in Canadian and US clinical guidance for individuals using fentanyl – is associated with improved treatment retention and lower risk of ...
The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...
Chronic illness has a way of sharpening your perspective. It exposes where systems rely heavily on patient endurance and how quickly women’s symptoms can be minimized.
And we respect that! But maybe you’re of a mind to support our work directly instead? We have until December 31 to raise the ...
Discover the top 10 weight loss medications of 2026. Explore how advanced GLP-1 therapies and combination drugs are reshaping ...
MedPage Today on MSN
Navy Recruits Doctors by Appealing to Administrative Frustrations
Ad campaign has popped up in four major cities ...
This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks ...
CHICAGO, April 20, 2026 /PRNewswire/ -- Experts from NYU Langone Health's Department of Neurology present their latest clinical findings and research discoveries at the American Academy of Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results